BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18438939)

  • 1. Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death.
    Yao SY; Soutto M; Sriram S
    J Neurosci Res; 2008 Aug; 86(11):2403-13. PubMed ID: 18438939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial cell wall products increases stabilization of HIF-1 alpha in an oligodendrocyte cell line preconditioned by cobalt chloride or desferrioxamine.
    Yao SY; Soutto M; Sriram S
    J Neuroimmunol; 2008 Aug; 200(1-2):17-26. PubMed ID: 18715655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms.
    Guo M; Song LP; Jiang Y; Liu W; Yu Y; Chen GQ
    Apoptosis; 2006 Jan; 11(1):67-77. PubMed ID: 16374551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis, necrosis and hypoxia inducible factor-1 in human head and neck squamous cell carcinoma cultures.
    Gross J; Fuchs J; Machulik A; Jahnke V; Kietzmann T; Bockmühl U
    Int J Oncol; 2005 Sep; 27(3):807-14. PubMed ID: 16077932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metavanadate suppresses desferrioxamine-induced leukemic cell differentiation with reduced hypoxia-inducible factor-1alpha protein.
    Xue ZH; Jiang Y; Yu Y; Wang LS; Chen GQ; Zhao Q
    Biochem Biophys Res Commun; 2005 Jul; 332(4):1140-5. PubMed ID: 15935329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells.
    Yang YT; Ju TC; Yang DI
    J Neurochem; 2005 May; 93(3):513-25. PubMed ID: 15836611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia inducible factor-1 alpha induction by tumour necrosis factor-alpha, but not by toll-like receptor agonists, modulates cellular respiration in cultured human hepatocytes.
    Regueira T; Lepper PM; Brandt S; Ochs M; Vuda M; Takala J; Jakob SM; Djafarzadeh S
    Liver Int; 2009 Nov; 29(10):1582-92. PubMed ID: 19744167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1alpha expression in response to lipopolysaccaride mediates induction of hepatic inflammatory cytokine TNFalpha.
    Kim HY; Kim YH; Nam BH; Kong HJ; Kim HH; Kim YJ; An WG; Cheong J
    Exp Cell Res; 2007 May; 313(9):1866-76. PubMed ID: 17451682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
    Minchenko O; Opentanova I; Minchenko D; Ogura T; Esumi H
    FEBS Lett; 2004 Oct; 576(1-2):14-20. PubMed ID: 15474002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of hypoxia on taxol-induced apoptosis in human ovarian cancer cell line A2780 and its mechanism].
    Huang L; Ao QL; Li F; Xing H; Lu YP; Ma D
    Ai Zheng; 2005 Apr; 24(4):408-13. PubMed ID: 15820061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer.
    Hervouet E; Cízková A; Demont J; Vojtísková A; Pecina P; Franssen-van Hal NL; Keijer J; Simonnet H; Ivánek R; Kmoch S; Godinot C; Houstek J
    Carcinogenesis; 2008 Aug; 29(8):1528-37. PubMed ID: 18515279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt induces hypoxia-inducible factor-1alpha (HIF-1alpha) in HeLa cells by an iron-independent, but ROS-, PI-3K- and MAPK-dependent mechanism.
    Triantafyllou A; Liakos P; Tsakalof A; Georgatsou E; Simos G; Bonanou S
    Free Radic Res; 2006 Aug; 40(8):847-56. PubMed ID: 17015263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress.
    Martínez-Romero R; Martínez-Lara E; Aguilar-Quesada R; Peralta A; Oliver FJ; Siles E
    J Cell Biochem; 2008 Aug; 104(6):2248-60. PubMed ID: 18459142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain.
    Jones NM; Bergeron M
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1105-14. PubMed ID: 11524615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions.
    Chen C; Yu Z
    Anticancer Res; 2009 Apr; 29(4):1367-72. PubMed ID: 19414389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes.
    Choi JH; Cho HK; Choi YH; Cheong J
    Biochem J; 2009 Nov; 424(2):285-96. PubMed ID: 19712049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
    Hao J; Song X; Song B; Liu Y; Wei L; Wang X; Yu J
    Cancer Gene Ther; 2008 Jul; 15(7):449-55. PubMed ID: 18421307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
    Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
    Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.